Number of the records: 1
Polycystin-1 is required for insulin-like growth factor 1-induced cardiomyocyte hypertrophy
SYS 0550595 005 20240103230329.1 014 $a 000686033500008 $2 WOS 017 70
$a 10.1371/journal.pone.0255452 $2 DOI 101 0-
$a eng 102 $a US 200 1-
$a Polycystin-1 is required for insulin-like growth factor 1-induced cardiomyocyte hypertrophy 215 $a 15 s. 463 -1
$1 001 cav_un_epca*0310005 $1 011 $a 1932-6203 $e 1932-6203 $1 200 1 $a PLoS ONE $v Roč. 16, č. 8 (2021) $1 205 $a ONLINE $1 210 $c Public Library of Science 608 $a Article 610 $a factor-i receptor 610 $a cardiac-hypertrophy 610 $a protein 610 $a calcium 610 $a deletion 700 -1
$3 cav_un_auth*0422728 $a Fernandez $b C. $y CL $4 070 $q Univ Chile, Fac Chem & Pharmaceut Sci, Santiago, Chile, Univ Chile, Fac Med, Adv Ctr Chron Dis ACCDiS, Santiago, Chile, Pontificia Univ Catolica Chile, Santiago, Chile 701 -1
$3 cav_un_auth*0387874 $a Torrealba $b Natalia $p BTO-N $i Laboratoř nádorové rezistence $j Laboratory of Tumour Resistance $y CL $T Biotechnologický ústav AV ČR, v. v. i. 701 -1
$3 cav_un_auth*0422729 $a Altamirano $b F. $y US $4 070 $q Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Div Cardiol, Dallas, TX 75390 USA, Houston Methodist Res Inst, DeBakey Heart & Vasc Ctr, Dept Cardiovasc Sci, Houston, TX USA, Cornell Univ, Weill Cornell Med Coll, Dept Cardiothorac Surg, Ithaca, NY 14850 USA $A 0000-0002-1612-2729 $B I-1928-2013 701 -1
$3 cav_un_auth*0422730 $a Garrido-Moreno $b V. $y CL $4 070 $q Univ Chile, Fac Chem & Pharmaceut Sci, Santiago, Chile, Univ Chile, Fac Med, Adv Ctr Chron Dis ACCDiS, Santiago, Chile, Pontificia Univ Catolica Chile, Santiago, Chile 701 -1
$3 cav_un_auth*0422731 $a Vasquez-Trincado $b C. $y CL $4 070 $q Univ Chile, Fac Chem & Pharmaceut Sci, Santiago, Chile, Univ Chile, Fac Med, Adv Ctr Chron Dis ACCDiS, Santiago, Chile, Pontificia Univ Catolica Chile, Santiago, Chile $A 0000-0003-2606-6860 701 -1
$3 cav_un_auth*0422732 $a Flores-Vergara $b R. $y CL $4 070 $q Univ Chile, Fac Chem & Pharmaceut Sci, Santiago, Chile, Univ Chile, Fac Med, Adv Ctr Chron Dis ACCDiS, Santiago, Chile, Pontificia Univ Catolica Chile, Santiago, Chile, Univ Chile, Inst Ciencias Biomed, Fac Med, Programa Fisiol & Biofis, Santiago, Chile 701 -1
$3 cav_un_auth*0422733 $a Lopez-Crisosto $b C. $y CL $4 070 $q Univ Chile, Fac Chem & Pharmaceut Sci, Santiago, Chile, Univ Chile, Fac Med, Adv Ctr Chron Dis ACCDiS, Santiago, Chile, Pontificia Univ Catolica Chile, Santiago, Chile, Pontificia Univ Catolica Chile, Fac Med, Div Cardiovasc Dis, Santiago, Chile 701 -1
$3 cav_un_auth*0422734 $a Ocaranza $b M. P. $y CL $4 070 $q Univ Chile, Fac Chem & Pharmaceut Sci, Santiago, Chile, Univ Chile, Fac Med, Adv Ctr Chron Dis ACCDiS, Santiago, Chile, Pontificia Univ Catolica Chile, Santiago, Chile, Pontificia Univ Catolica Chile, Fac Med, Div Cardiovasc Dis, Santiago, Chile, Pontificia Univ Catolica Chile, Ctr New Drugs Hypertens CENDHY, Santiago, Chile 701 -1
$3 cav_un_auth*0422735 $a Chiong $b M. $y CL $4 070 $q Univ Chile, Fac Chem & Pharmaceut Sci, Santiago, Chile, Univ Chile, Fac Med, Adv Ctr Chron Dis ACCDiS, Santiago, Chile, Pontificia Univ Catolica Chile, Santiago, Chile 701 -1
$3 cav_un_auth*0422736 $a Pedrozo $b Z. $y CL $4 070 $z K $q Univ Chile, Fac Chem & Pharmaceut Sci, Santiago, Chile, Univ Chile, Fac Med, Adv Ctr Chron Dis ACCDiS, Santiago, Chile, Pontificia Univ Catolica Chile, Santiago, Chile, Univ Chile, Inst Ciencias Biomed, Fac Med, Programa Fisiol & Biofis, Santiago, Chile 701 -1
$3 cav_un_auth*0422737 $a Lavandero $b S. $y CL $4 070 $z K $q Univ Chile, Fac Chem & Pharmaceut Sci, Santiago, Chile, Univ Chile, Fac Med, Adv Ctr Chron Dis ACCDiS, Santiago, Chile, Pontificia Univ Catolica Chile, Santiago, Chile, Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Div Cardiol, Dallas, TX 75390 USA, Corp Ctr Estudios Cient Enfermedades Cron CECEC, Santiago, Chile 856 $u https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0255452 $9 RIV
Number of the records: 1